Diqq al-Shaykhūkha and Sarcopenia: A Historical and Conceptual Review of Muscle Wasting in Old Age
Abstract
Background: Age-related decline in muscle mass and function is a significant contributor to morbidity in the elderly. In modern medicine, this condition is recognized as sarcopenia. Classical Unani literature describes a comparable condition termed Diqq al-Shaykhūkha, characterized by progressive weakness and wasting in old age. Objective: To explore the historical and conceptual understanding of Diqq al-Shaykhūkha in Unani medicine and to compare it with the modern biomedical concept of sarcopenia. Methods: A narrative and historical review was conducted. Classical Unani texts, including works of Ibn Sīnā, Rāzī, and Jurjānī, were analyzed for descriptions of aging and wasting disorders. Contemporary literature on sarcopenia was retrieved from databases such as PubMed, Web of Science, and Google Scholar using relevant keywords. A comparative thematic analysis was performed. Results: The analysis revealed substantial similarities between Diqq al-Shaykhūkha and sarcopenia in terms of age of onset, progressive muscle wasting, associated weakness, and contributing factors such as inadequate nutrition and reduced physical activity. While Unani medicine explains the condition through concepts like diminished Harārat Gharīziyya and increased dryness, modern medicine attributes it to multifactorial mechanisms including aging, inflammation, and hormonal changes. Preventive strategies in both systems emphasize diet and physical activity. Conclusion: Diqq al-Shaykhūkha can be regarded as an early conceptualization of age-related muscle wasting analogous to sarcopenia. Recognizing this relationship highlights the continuity of medical knowledge across traditions and supports the integration of historical insights into contemporary geriatric research.
Keywords:
Diqq al-Shaykhūkha; Sarcopenia; Unani Medicine; Aging; Muscle Wasting; History of Medicine
Keywords:
Diqq al-Shaykhūkha, Sarcopenia, Unani Medicine, Aging, Muscle Wasting, History of MedicineDOI
https://doi.org/10.22270/jddt.v16i10.8027References
1. Zhang, F.-M.; Wu, H.-F.; Shi, H.-P.; Yu, Z.; Zhuang, C.-L. Sarcopenia and malignancies:Epidemiology, clinical classification and implications. Ageing Res. Rev. 2023, 91, 102057. https://doi.org/10.1016/j.arr.2023.102057 PMid:37666432
2 .Feike, Y.; Zhijie, L.; Wei, C. Advances in research on pharmacotherapy of sarcopenia. Aging Med. 2021, 4, 221-23 https://doi.org/10.1002/agm2.12168 PMid:34553120 PMCid:PMC8444957
3.Sharma N, et al.Sarcopenia and its determinants among urban Inadian and healthysubjects:an exploratory study. Acta Sci Nutr Health.2025,9(6):91-97
4.Jung HN, Jung CH, Hwang YC. Sarcopenia in youth. Metabolism. 2023;144:155557. doi:10.1016/j.metabol.2023.155557 https://doi.org/10.1016/j.metabol.2023.155557 PMid:37080353
5 .Yuan, S.; Larsson, S.C. Epidemiology of sarcopenia: Prevalence, risk factors, andconsequences. Metabolism 2023, 144, 155533. https://doi.org/10.1016/j.metabol.2023.155533 PMid:36907247
6. Zhang, X.; Huang, P.; Dou, Q.; Wang, C.; Zhang, W.; Yang, Y.; Wang, J.; Xie, X.; Zhou, J.; Zeng, Y. Falls among older adults with sarcopenia dwelling in nursing home or community: A meta-analysis. Clin. Nutr. 2020, 39, 33-39. https://doi.org/10.1016/j.clnu.2019.01.002 PMid:30665817
7.Cai, Z.; Liu, D.; Yang, Y.; Xie, W.; He, M.; Yu, D.; Wu, Y.; Wang, X.; Xiao, W.; Li, Y. The role and therapeutic potential of stem cells in skeletal muscle in sarcopenia. Stem Cell Res. Ther. 2022, 13, 28. https://doi.org/10.1186/s13287-022-02706-5 PMid:35073997 PMCid:PMC8785537
8. Kwak, J.Y.; Kwon, K.S. Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia. Ann. Geriatr. Med. Res. 2019, 23, 98-104. https://doi.org/10.4235/agmr.19.0028 PMid:32743297 PMCid:PMC7370765
9.Hardee, J.P.; Lynch, G.S. Current pharmacotherapies for sarcopenia. Expert Opin. Pharmacother. 2019, 20, 1645-1657. https://doi.org/10.1080/14656566.2019.1622093 PMid:31120352
10.Rooks, D.; Swan, T.; Goswami, B.; Filosa, L.A.; Bunte, O.; Panchaud, N.; Coleman, L.A.;Miller, R.R.; Garcia Garayoa, E.; Praestgaard, J.; et al. Bimagrumab vs Optimized Standardof Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A RandomizedClinical Trial. JAMA Netw. Open 2020, 3, e2020836. https://doi.org/10.1001/jamanetworkopen.2020.20836 PMid:33074327 PMCid:PMC7573681
11. Agostini, F.; Bernetti, A.; Di Giacomo, G.; Viva, M.G.; Paoloni, M.; Mangone, M.; Santilli, V.; Masiero, S. Rehabilitative Good Practices in the Treatment of Sarcopenia: ANarrative Review. Am. J. Phys. Med. Rehabil. 2021, 100, 280-287. https://doi.org/10.1097/PHM.0000000000001572 PMid:33595941
12.Landi, F.; Marzetti, E.; Martone, A.M.; Bernabei, R.; Onder, G. Exercise as a remedy for sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17, 25-31. https://doi.org/10.1097/MCO.0000000000000018 PMid:24310054
13.Hurst, C.; Robinson, S.M.; Witham, M.D.; Dodds, R.M.; Granic, A.; Buckland, C.; DeBiase, S.; Finnegan, S.; Rochester, L.; Skelton, D.A.; et al. Resistance exercise as a treatmentfor sarcopenia: Prescription and delivery. Age Ageing 2022, 51, afac003. https://doi.org/10.1093/ageing/afac003 PMid:35150587 PMCid:PMC8840798
14.Sina I. Al Qanoon Fil Tib (Urdu Trans: Kantoori GH). New Delhi: Idara Kitabu-Us-Shifa;p. 1204-1205.
15.Kirmani NA. Sharah Asbab. Darya Ganj: Aijaz Publishing House; 2012. p. 408 12
16. Kabiruddin HM, translator and annotator. Ḥimāyat-e-Qānūn. Ḥissa Duwam [Urdu]. NewDelhi: Central Council for Research in Unani Medicine (CCRUM), Ministry of AYUSH, Government of India;P. 36-37
17. Farooqi AH. Kitab al-Ḥummayāt (Muʿālajāt). P.126-127
18.Kabiruddin HM. Al-Aksir. Delhi: Matba’ Kabir Printing Works; P. 1609-1610
19. Baghdadi IH .Kitab al-Mukhtarat fial-Tibb (Urdu Trans).New Delhi.Central Council forResearch in Unani Medicine (CCRUM),Ministry of AYUSH, Government of India p. 236-237.
20. Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636-2646. doi:10.1016/S0140-6736(19)31138-9. PMID: 31171417. https://doi.org/10.1016/S0140-6736(19)31138-9 PMid:31171417 PMCid:PMC10727540
21. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412-423. doi:10.1093/ageing/afq034. PMID: 20392703. https://doi.org/10.1093/ageing/afq034 PMid:20392703
22. Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR). J Nutr Health Aging. 2018;22(10):1148-1161. doi:10.1007/s12603-018-1139-9. PMID: 30498820. https://doi.org/10.1007/s12603-018-1139-9 PMid:30498820 PMCid:PMC12280515
23 Green BN, Johnson CD, Adams A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006;5(3):101-117. doi:10.1016/S0899-3467(07)60142-6 https://doi.org/10.1016/S0899-3467(07)60142-6 PMid:19674681
24 Hippocrates.Aphorisms. (Arabic/Unani translations in classical compilations).
25 Galen.Kitab fi al-Quwa al-Tabi’iyya (On the Natural Faculties). (Arabic translation).
26 Rāzī Z. Al-Hāwī fi al-Tibb (Liber Continens). Hyderabad: Dairat-ul-Maarif
27 Jurjānī I. Zakhīra Khwārazm Shāhī. Tehran: Bunyad-e Farhang.
28 Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-991S. https://doi.org/10.1093/jn/127.5.990S PMid:9164280
29 Jensen GL. Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr. 2008;32(6):656-659. doi:10.1177/0148607108324585 https://doi.org/10.1177/0148607108324585 PMid:18974248
30 Coelho-Junior HJ, Calvani R, Azzolino D, et al. Protein Intake and Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022;19(14):8718. Published 2022 Jul 18. doi:10.3390/ijerph19148718 https://doi.org/10.3390/ijerph19148718 PMid:35886571 PMCid:PMC9320473
31 Araújo LP, Figueiredo Godoy AC, Fortes Frota F, et al. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. Int J Mol Sci. 2025;26(24):12147. Published 2025 Dec 17. doi:10.3390/ijms262412147 https://doi.org/10.3390/ijms262412147 PMid:41465572 PMCid:PMC12734266
32 Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One. 2017;12(1):e0169548. Published 2017 Jan 17. doi:10.1371/journal.pone.0169548s https://doi.org/10.1371/journal.pone.0169548 PMid:28095426 PMCid:PMC5240970
33 Kim TN, Choi KM. Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab. 2013;20(1):1-10. doi:10.11005/jbm.2013.20.1.1 https://doi.org/10.11005/jbm.2013.20.1.1 PMid:24524049 PMCid:PMC3780834
34 Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2014;11(3):177-180. https://doi.org/10.11138/ccmbm/2014.11.3.177
35 Malik Itrat. (2020)
Methods of health promotion and disease prevention in Unani medicine.
J Educ Health Promot. 2020;9:168.
PMID: 33015201
36 Song Z, Pan T, Tong X, Yang Y, Zhang Z. The effects of nutritional supplementation on older sarcopenic individuals who engage in resistance training: a meta-analysis. Front Nutr. 2023;10:1109789. Published 2023 Apr 25. doi:10.3389/fnut.2023.1109789 https://doi.org/10.3389/fnut.2023.1109789 PMid:37181154 PMCid:PMC10167299
37 Xie C, Yan R, Tao R. Combined resistance training and amino acid-based supplementation for sarcopenia in older adults: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2026;27(1):35. Published 2026 Jan 15. doi:10.1186/s12891-025-09436-8 https://doi.org/10.1186/s12891-025-09436-8 PMid:41540398 PMCid:PMC12809905
38 Coelho-Junior HJ, Calvani R, Azzolino D, et al. Protein Intake and Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022;19(14):8718. Published 2022 Jul 18. doi:10.3390/ijerph19148718 https://doi.org/10.3390/ijerph19148718 PMid:35886571 PMCid:PMC9320473
39 Li ML, Zhang F, Luo HY, et al. Improving sarcopenia in older adults: a systematic review and meta-analysis of randomized controlled trials of whey protein supplementation with or without resistance training. J Nutr Health Aging. 2024;28(4):100184. doi:10.1016/j.jnha.2024.100184 https://doi.org/10.1016/j.jnha.2024.100184 PMid:38350303 PMCid:PMC12877251
40 Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi:10.1093/ageing/afy169 https://doi.org/10.1093/ageing/afy169 PMid:30312372
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Mubashshera Shaikh , Abdul Rehman M.I. , Syed Mohd Abbas Zaidi , Meraj Meraj
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.